Malaria: Return on Investment

Photo: PATH

As if saving 10 million lives and averting nearly 3 billion malaria cases wasn’t enough, meeting the 2030 malaria targets1 recently established by the global malaria community would also generate more than US$2 trillion in additional economic output worldwide. Hardly a new concept, the benefits of investing in the malaria fight and the importance of sustained funding serve as the basis for many great resources—including the ones detailed below.

Explore these resources to learn about the multiple benefits of investing in malaria, then use our messages to spread the word!

infographicThere is much to gain from eliminating malaria—millions more lives saved and an estimated $2 trillion boost to the global economy—and too much at stake to fail. Learn more about the potential return on investment for eliminating malaria in the Investing in Malaria Pays Off infographic.

Tweetable facts:

10 million lives could be saved if the #GlobalGoals are met. Investing in #malaria pays off.

6.2 million lives have been saved since 2000. Investing in #malaria pays off.

Malaria-free countries have 5x greater economic growth than countries with #malaria

Investing in #malaria pays off. Tools to prevent & decrease transmission are cost-effective.

AIM reportThe complementary Global Technical Strategy for Malaria and Action and Investment to Defeat Malaria (AIM) documents lay out the technical strategies required to continue driving down the burden of malaria, while charting the investment and collective actions needed to reach the 2030 malaria goals.

Tweetable facts:

#Malaria can negatively affect macroeconomic performance & is a determinant of long-term economic growth.

Less #malaria means more cohesive, stable societies that can attract international investors and trade.

No #malaria means less worker absenteeism, increased productivity in agriculture, business, and industry.

Private Sector report coverBusiness Investing in Malaria Control: Economic Returns and a Healthy Workforce for Africa by the Roll Back Malaria Partnership examines how private sector investment in malaria control has improved cost effectiveness at companies operating in malaria-endemic regions in Africa. Companies in Equatorial Guinea, Ghana, Mozambique, and Zambia have worked to prevent malaria among their workers and workers’ dependents and have seen an excellent return on investment, with significant reductions in malaria-related illnesses and deaths, worker absenteeism, and malaria-related spending.

Tweetable facts:

Nearly 3/4 of African companies report that #malaria was negatively affects their business.

In #Zambia, 3 company clinics step up #malaria control and see 28% annualized rate of return.

Private sector + national programs = durable, long term success against #malaria.

.@MarathonOil and partners reduced #malaria in children by >50% in Equatorial Guinea.

Ghana and @AGAColombia took company monthly #malaria med spending from USD$550K to 9800

Mozambique: BHP Billiton helps reduce #malaria infections from 625 to 200 cases per 1000.

Maintaing the Gains coverMaintaining the Gains in Global Malaria Control: The Health and Economic Benefits of Sustaining Control Measures by UCSF, co-authored by the African Leaders Malaria Alliance (ALMA), the Evidence to Policy Initiative (E2Pi) in UCSF’s Global Health Group, and the Clinton Health Access Initiative (CHAI), is a valuable resource.

Thanks to aggressive campaigns to scale up control tools, many malaria-endemic countries have seen dramatic falls in malaria cases and deaths.

Alongside the report are country briefs highlighting successes in Ethiopia, Rwanda, Senegal, Tanzania (Mainland and Zanzibar). If these successful countries can sustain their control activities, they will reap impressive public health and economic benefits.

Tweetable facts:

Estimated ROI of sustained #malaria control in #Ethiopia, 2011-2015: $39million in treatment costs averted.

Estimated ROI of sustained #malaria control in #Rwanda, 2011-2015: $267mill in treatment costs averted.

Estimated ROI of sustained #malaria control in #Zambia 2011-2015 = $347million in treatment costs averted

Estimated ROI of sustained #malaria control in #Zanzibar, 2011-2015: $3.2mill in treatment costs averted.

#Malaria investment is a best buy; similar in cost effectiveness to #vaccines.

Cost of Inaction

The messages in Cost of Inaction: A report on how inadequate investment in the Global Fund to Fight AIDS, Tuberculosis and Malaria will affect millions of lives by International Civil Society Support referring specifically to the Global Fund provide great context for the overall benefits of funding malaria, as well as the consequences of complacency.

Tweetable facts:

$1 investment in #malaria prevention and treatment delivers a return of $20.

The world could gain an estimated $208 billion by 2035 through progress against #malaria.

Business and malariaBusiness and Malaria: A Neglected Threat? by the World Economic Forum analyzes the impact of malaria on businesses, citing specific examples of burden and of success control programs, and provides recommendations for the private sector.

Tweetable facts:

Almost 3/4 of Ghanaian businesses believe #malaria eradication would increase productivity.

US$3million for @ExonMobile’s #malaria program yielded 8.9 million in productivity gains.


  1. Which are:

    • Reduce malaria mortality rates globally by 90 percent.
    • Reduce malaria case incidence globally by 90 percent.
    • Eliminate the disease in at least 35 more countries.
    • Prevent re-establishment of malaria in all countries that are malaria-free.